-
Something wrong with this record ?
Evidence of Hypothalamic-Pituitary-Adrenal and -Gonadal Dysfunction in Cocaine-Addicted Men
KD. Ersche, J. Stochl, AB. Brühl, M. Gurnell
Language English Country Switzerland
Document type Randomized Controlled Trial, News
PubMed
38219711
DOI
10.1159/000535584
Knihovny.cz E-resources
- MeSH
- Adrenocorticotropic Hormone MeSH
- Atomoxetine Hydrochloride pharmacology MeSH
- Hydrocortisone MeSH
- Hypogonadism * MeSH
- Cocaine * MeSH
- Quality of Life MeSH
- Humans MeSH
- Cocaine-Related Disorders * MeSH
- Substance-Related Disorders * MeSH
- Pituitary-Adrenal System MeSH
- Hypothalamo-Hypophyseal System MeSH
- Testosterone MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Publication type
- Randomized Controlled Trial MeSH
- News MeSH
INTRODUCTION: Regular cocaine use has been associated with hormonal dysfunction including hypogonadism, which can lead to fatigue, reduced stamina, sexual dysfunction, and impaired quality of life. However, cocaine's endocrine effects are largely under-reported in the scientific addiction literature and, in many cases, are not addressed within treatment services. The low profile of these adverse effects might be attributable to a lack of awareness and linkage with cocaine use, such that they are recognized only when an acute/emergency problem arises. METHODS: We assessed endocrine diurnal function (adrenocorticotrophic hormone [ACTH], cortisol, and testosterone) in 26 healthy and 27 cocaine-dependent men and examined changes in hormone levels in response to a single 40 mg dose of the noradrenaline re-uptake inhibitor atomoxetine in a double-blind, placebo-controlled experimental medicine study. RESULTS: When compared with healthy controls, diurnal and atomoxetine-induced changes in ACTH and cortisol showed greater variability in cocaine-dependent men. Interestingly, despite an exaggerated rise in ACTH following atomoxetine, an attenuated cortisol response was observed, and one-third of cocaine-dependent men had subnormal testosterone levels. CONCLUSION: Our findings point to a potential disconnection between the pituitary and adrenal responses in cocaine-dependent men, a higher rate of hypogonadism, and a pressing need for more research into the endocrine effects of cocaine and their clinical implications.
Department of Kinanthropology Charles University Prague Czechia
Department of Psychiatry University Hospital of Psychiatry University of Basel Basel Switzerland
Department of Psychiatry University of Cambridge Cambridge UK
Department of Systems Neuroscience University Medical Center Hamburg Eppendorf Hamburg Germany
NIHR Cambridge Biomedical Research Centre Cambridge University Hospitals Cambridge UK
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24014600
- 003
- CZ-PrNML
- 005
- 20240905133905.0
- 007
- ta
- 008
- 240725s2024 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000535584 $2 doi
- 035 __
- $a (PubMed)38219711
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Ersche, Karen D $u Department of Psychiatry, University of Cambridge, Cambridge, UK $u Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany $u Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 245 10
- $a Evidence of Hypothalamic-Pituitary-Adrenal and -Gonadal Dysfunction in Cocaine-Addicted Men / $c KD. Ersche, J. Stochl, AB. Brühl, M. Gurnell
- 520 9_
- $a INTRODUCTION: Regular cocaine use has been associated with hormonal dysfunction including hypogonadism, which can lead to fatigue, reduced stamina, sexual dysfunction, and impaired quality of life. However, cocaine's endocrine effects are largely under-reported in the scientific addiction literature and, in many cases, are not addressed within treatment services. The low profile of these adverse effects might be attributable to a lack of awareness and linkage with cocaine use, such that they are recognized only when an acute/emergency problem arises. METHODS: We assessed endocrine diurnal function (adrenocorticotrophic hormone [ACTH], cortisol, and testosterone) in 26 healthy and 27 cocaine-dependent men and examined changes in hormone levels in response to a single 40 mg dose of the noradrenaline re-uptake inhibitor atomoxetine in a double-blind, placebo-controlled experimental medicine study. RESULTS: When compared with healthy controls, diurnal and atomoxetine-induced changes in ACTH and cortisol showed greater variability in cocaine-dependent men. Interestingly, despite an exaggerated rise in ACTH following atomoxetine, an attenuated cortisol response was observed, and one-third of cocaine-dependent men had subnormal testosterone levels. CONCLUSION: Our findings point to a potential disconnection between the pituitary and adrenal responses in cocaine-dependent men, a higher rate of hypogonadism, and a pressing need for more research into the endocrine effects of cocaine and their clinical implications.
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hydrokortison $7 D006854
- 650 _2
- $a atomoxetin $x farmakologie $7 D000069445
- 650 _2
- $a kvalita života $7 D011788
- 650 _2
- $a adrenokortikotropní hormon $7 D000324
- 650 12
- $a poruchy spojené s užíváním kokainu $7 D019970
- 650 12
- $a kokain $7 D003042
- 650 _2
- $a systém hypotalamus-hypofýza $7 D007030
- 650 12
- $a hypogonadismus $7 D007006
- 650 _2
- $a testosteron $7 D013739
- 650 12
- $a poruchy spojené s užíváním psychoaktivních látek $7 D019966
- 650 _2
- $a systém hypofýza - nadledviny $7 D010913
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 655 _2
- $a zprávy $7 D016433
- 700 1_
- $a Stochl, Jan $u Department of Psychiatry, University of Cambridge, Cambridge, UK $u Department of Kinanthropology, Charles University, Prague, Czechia
- 700 1_
- $a Brühl, Annette B $u Department of Psychiatry, University of Cambridge, Cambridge, UK $u Department of Psychiatry, University Hospital of Psychiatry, University of Basel, Basel, Switzerland
- 700 1_
- $a Gurnell, Mark $u Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK $u NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals, Cambridge, UK
- 773 0_
- $w MED00007942 $t European addiction research $x 1421-9891 $g Roč. 30, č. 2 (2024), s. 114-120
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38219711 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905133859 $b ABA008
- 999 __
- $a ok $b bmc $g 2144019 $s 1226466
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 30 $c 2 $d 114-120 $e 20240112 $i 1421-9891 $m European addiction research $n Eur Addict Res $x MED00007942
- LZP __
- $a Pubmed-20240725